Is ABBV or GILD cheaper?

On trailing earnings, GILD is cheaper: ABBV trades at a 111.67 P/E and GILD at 17.11.

Which has grown faster, ABBV or GILD?

Over the past five years, ABBV grew revenue faster — ABBV at a 4.59% CAGR versus GILD at 3.07%.

Does ABBV or GILD pay a bigger dividend?

ABBV yields 2.96% and GILD yields 1.91% based on trailing dividends and the latest price.

Is ABBV or GILD more profitable?

GILD runs the higher net margin — ABBV at 5.79% versus GILD at 30.99%.

Which has been the better investment, ABBV or GILD?

Over the past 10-year, ABBV delivered the higher annualized total return — ABBV at 18.88% versus GILD at 7.79%. Past performance doesn't predict future results.

AbbVie Inc. (ABBV) vs Gilead Sciences, Inc. (GILD)

GILD leads on 11 of 14 compared metrics.

A side-by-side comparison of AbbVie Inc. and Gilead Sciences, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of June 14, 2026. The ● marks the stronger figure on each row (cheaper multiple, higher margin/return).

Gilead Sciences, Inc.

$155.93B

$125.59Healthcare

Total return — ABBV vs GILD

growth of $100 · last 14y

ABBV +550.7%GILD +238.2%ABBV compounded faster

ABBV GILD

ABBV vs GILD: by the numbers

•ABBV is the larger company ($402.35B vs $155.93B market cap).
•GILD trades at the lower earnings multiple (17.11 vs 111.67 P/E).
•GILD converts more revenue to profit (30.99% vs 5.79% net margin).
•ABBV grew revenue faster over the past five years (4.59% vs 3.07% CAGR).
•ABBV pays the higher dividend yield (2.96% vs 1.91%).

Which is better, ABBV or GILD?

Metric tally: ABBV 3 · GILD 11

It depends on what you're optimizing for:

ValueGILD(lower P/E)

GrowthABBV(faster 5Y revenue CAGR)

IncomeABBV(higher dividend yield)

QualityGILD(higher ROIC)

Valuation

Metric	ABBV	GILD
P/E ratio	111.67	17.11●
Forward P/E	—	13.00
P/S ratio	6.43	5.30●
P/B ratio	14.69	6.70●
PEG ratio	—	0.01
EV / EBITDA	27.63	12.91●
FCF yield	5.17%	6.49%●

Profitability

Metric	ABBV	GILD
Gross margin	70.68%	79.35%●
Operating margin	27.60%	38.26%●
Net margin	5.79%	30.99%●
ROE	13.23%	39.19%●
ROIC	12.97%	21.53%●

Dividends

Metric	ABBV	GILD
Dividend yield	2.96%●	1.91%
Payout ratio	284.39%	35.09%

Growth (annualized)

Metric	ABBV	GILD
Revenue CAGR (5Y)	4.59%●	3.07%
EPS CAGR (5Y)	-2.79%	133.83%●
FCF CAGR (5Y)	3.24%	3.30%
Total return CAGR (5Y)	18.95%●	17.06%

Frequently asked

Which is better, ABBV or GILD?: It depends on your goal. value: GILD (lower P/E); growth: ABBV (faster 5Y revenue CAGR); income: ABBV (higher dividend yield); quality: GILD (higher ROIC). Across all compared metrics, GILD leads 11 to 3.
Is ABBV or GILD cheaper?: On trailing earnings, GILD is cheaper: ABBV trades at a 111.67 P/E and GILD at 17.11.
Which has grown faster, ABBV or GILD?: Over the past five years, ABBV grew revenue faster — ABBV at a 4.59% CAGR versus GILD at 3.07%.
Does ABBV or GILD pay a bigger dividend?: ABBV yields 2.96% and GILD yields 1.91% based on trailing dividends and the latest price.
Is ABBV or GILD more profitable?: GILD runs the higher net margin — ABBV at 5.79% versus GILD at 30.99%.
Which has been the better investment, ABBV or GILD?: Over the past 10-year, ABBV delivered the higher annualized total return — ABBV at 18.88% versus GILD at 7.79%. Past performance doesn't predict future results.

Go deeper

Full ABBV analysis Full GILD analysis Interactive comparison tool

Dig into the metrics

AbbVie P/E ratio Gilead Sciences P/E ratio AbbVie dividend yield Gilead Sciences dividend yield AbbVie ROE Gilead Sciences ROE AbbVie operating margin Gilead Sciences operating margin AbbVie revenue growth Gilead Sciences revenue growth AbbVie free cash flow Gilead Sciences free cash flow

AbbVie & Gilead Sciences appear in these rankings

Highest Dividend Yield Stocks Dividend Aristocrats Highest ROE Stocks Highest ROIC Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified June 14, 2026.